Is CPT code 87798 the correct code to report for testing on a direct specimen (primary source) for the detection of antibiotic resistance genes (other than MRSA and enterococcus species van A, van B) and virulence factor genes (eg, alpha-hemolysin) using nucleic acid (DNA or RNA) amplified probe technique? ...
Subscribe or sign in to view the full article.
Article Overview
This article explains a CPT coding question about molecular testing performed on a direct specimen and discusses when a not-otherwise-specified infectious agent detection code is used for certain gene targets. It is useful for laboratory coders, billers, and compliance staff who work with nucleic acid amplification testing and need to understand the scope of the guidance.
Why This Topic Matters
Accurate reporting for molecular laboratory testing depends on matching the test performed to the correct CPT category. This guidance helps readers understand the general billing context for direct-specimen testing when more specific codes are not available.
What You Will Learn
- The general coding issue raised by direct-specimen molecular testing
- How the article frames use of a non-specific infectious agent detection CPT code
- The laboratory coding context for antibiotic resistance and virulence-related gene detection
- When more specific organism-related coding may affect reporting scope
Who Should Read This
- Laboratory coders
- Medical coders
- Billers
- Compliance staff
- Pathology and laboratory reimbursement staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com